Pharmaceutical companies in Denmark by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Novo Nordisk has the lowest figure of the 3 pharmaceutical companies in Denmark ranked by P/S ratio, at 3.8, followed by Genmab (8.4) and Ascendis Pharma (22.2). Figures as of 19 Nov 2026, 08:50 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
3
Lowest
Novo Nordisk3.8
Median
8.4
Combined market value
AED 818.8B
Countries
1

Market values as of .

Denmark
All sectors
Pharmaceuticals
AED
Clear filters
Pharmaceutical companies in Denmark by P/S ratio
#CompanyP/S ↑Market capPriceToday1 yearPrice, 30 daysCountry
1Novo NordiskNVO · Health Care3.8AED 638.2BAED 144.81 3.12% down 17% down Denmark
2GenmabGMAB · Health Care8.4AED 115.4BAED 187.19 1.91% down 70% up Denmark
3Ascendis PharmaASND · Health Care22.2AED 65.1BAED 992.81 0.32% down 28% up Denmark

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6726 AED).

Questions and answers

Which pharmaceutical companies in Denmark have the lowest P/S ratio?

Novo Nordisk (3.8), Genmab (8.4) and Ascendis Pharma (22.2) have the lowest P/S ratio of the 3 pharmaceutical companies in Denmark ranked here as of 19 Nov 2026, 08:50 UTC.

How many pharmaceutical companies in Denmark are in this ranking?

3 are ranked by P/S ratio.

What are these pharmaceutical companies in Denmark worth together?

The 3 pharmaceutical companies in Denmark ranked by P/S ratio have a combined market value of AED 818.8B as of 19 Nov 2026, 08:50 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Pharmaceutical companies in Denmark by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=denmark&by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.